ENDOmetriosis appearance with hormonal COntraceptives at LaparOscopy: a pRospective cohort study (ENDO-COLOR Trial)
Not Applicable
Recruiting
- Conditions
- EndometriosisReproductive Health and Childbirth - Other reproductive health and childbirth disorders
- Registration Number
- ACTRN12624000927527
- Lead Sponsor
- Sydney Minimally Invasive Gynaecology Research Group
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Recruiting
- Sex
- Female
- Target Recruitment
- 106
Inclusion Criteria
Women aged between 18-60 years of age undergoing laparoscopy for diagnosis and excision of suspected endometriosis.
Women with the capacity to give written consent freely
Exclusion Criteria
- Previous surgical excision of endometriosis
- Use of GNRH analogues, danazol, selective oestrogen receptor modulators in the 6 months prior to laparoscopy
- Patients unsure of their current or recent hormonal contraceptive use
- Pregnant women
Study & Design
- Study Type
- Observational
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method
Related Research Topics
Explore scientific publications, clinical data analysis, treatment approaches, and expert-compiled information related to the mechanisms and outcomes of this trial. Click any topic for comprehensive research insights.
What molecular pathways are modulated by hormonal contraceptives in endometriosis progression observed in the ENDO-COLOR Trial (ACTRN12624000927527)?
How do hormonal contraceptive regimens compare to standard-of-care therapies in reducing endometriosis-related adhesions during laparoscopy in ACTRN12624000927527?
Which biomarkers correlate with endometriosis lesion visibility under hormonal suppression in the ENDO-COLOR observational cohort?
What adverse events are associated with long-term hormonal contraceptive use in endometriosis patients enrolled in ACTRN12624000927527?
How do progestin-only versus combined estrogen-progestin contraceptives affect endometriosis recurrence rates in the ENDO-COLOR Trial's 18-60 year old cohort?